fda tirzepatide shortage update today backtracks over Eli Lilly weight-loss drug Compounders protest as FDA removes

This part is simple

Efficacy Comparison: Tirzepatide vs

By week 24 in clinical trials, patients on higher doses often achieved significant weight loss, with results continuing to improve with ongoing treatment

Right where many people find meaningful results

Many factors determine which medication is better for you

In its lawsuit, the group called the FDAs decision reckless and arbitrary, and argued that it would deprive patients of a vital treatment for type 2 diabetes and obesity. In a court filing, the FDA said pharmacists could resume making compounded tirzepatide as it reconsiders its decision to remove the drug from its shortage list